Clinical Trials on Colorectal Cancer Stage I in Singapore
Total 67 results
-
National University Hospital, SingaporeNational Cancer Centre, SingaporeUnknownErbB2-Positive Stage I-III Breast CancerSingapore
-
National University Hospital, SingaporeUnknownCancer (Advanced Stage)Singapore
-
National University Hospital, SingaporeUnknownAsian Colorectal Cancer PatientsSingapore
-
Merck KGaA, Darmstadt, GermanyMerck Pte. Ltd., SingaporeCompleted
-
Singapore General HospitalSinghealth FoundationCompletedColorectal Cancer MetastaticSingapore
-
National University Hospital, SingaporeTan Tock Seng HospitalUnknown
-
National University Hospital, SingaporeRecruiting
-
National Cancer Centre, SingaporeMerck Sharp & Dohme LLCRecruiting
-
Changi General HospitalCompleted
-
National University Health System, SingaporeCompletedColorectal CancerSingapore
-
AB ScienceTerminatedMetastatic Colorectal CancerFrance, Singapore, United Kingdom
-
National University Hospital, SingaporeUnknownColorectal CancerSingapore
-
National Medical Research Council (NMRC), SingaporeUnknownColorectal CancerChina, Singapore
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
National Cancer Centre, SingaporeBristol-Myers SquibbRecruitingHepatocellular Carcinoma | Colorectal Cancer | Liver Metastases | Colorectal Carcinoma | Hepatocellular CancerSingapore
-
National Cancer Centre, SingaporeSingapore General Hospital; Singapore Cancer Society; Genome Institute of Singapore and other collaboratorsRecruitingLocally Advanced Breast Cancer | Early-stage Breast CancerSingapore
-
Singapore General HospitalCompletedColorectal Cancer | Intestinal ObstructionSingapore
-
National Cancer Centre, SingaporeNovartisTerminatedGastric Cancer | Colorectal CancerSingapore
-
National University Health System, SingaporeRecruiting
-
Sidney Kimmel Comprehensive Cancer Center at Johns...CompletedStage T3-4NxM0 Gastric CancerSingapore
-
GlaxoSmithKlineCompletedPathologically Proven Stage I, II and III Non-Small Cell Lung Cancer (NSCLC)Singapore, Korea, Republic of
-
National Cancer Centre, SingaporeRecruitingColorectal Cancer | Pancreatic AdenocarcinomaSingapore
-
National Cancer Centre, SingaporeUnknownColorectal Cancer | Peritoneal MetastasesSingapore
-
National University Hospital, SingaporeUnknown
-
National University Hospital, SingaporeTan Tock Seng HospitalUnknownStage III Non-Small Cell Lung CancerSingapore
-
National University Hospital, SingaporeUnknownNasopharyngeal Cancer | Colorectal CancerSingapore
-
National University Hospital, SingaporeUnknownColorectal Cancer | Epithelial Ovarian Cancer | HNSCC | OrganoidsSingapore
-
Tan Tock Seng HospitalRecruitingAdvanced Cancer | Hyperactive Delirium | Olanzapine | Haloperidol | End-stage Organ DiseaseSingapore
-
University of ChicagoNational Cancer Institute (NCI)CompletedCastration-resistant Prostate Cancer | Stage IV Prostate CancerSingapore, United States
-
Queensland Centre for Gynaecological CancerThe University of QueenslandRecruitingSurgery | Sentinel Lymph Node | Endometrial Cancer Stage IAustralia, United States, Brazil, Singapore, India
-
National Cancer Centre, SingaporePfizerActive, not recruitingNSCLC Stage IV | NSCLC Stage IIIB | Recurrent NSCLC | NSCLC Stage IIIC | EGFR Positive Non-Small Cell Lung CancerKorea, Republic of, Hong Kong, Thailand, Singapore, Malaysia
-
Novartis PharmaceuticalsCompletedMetastatic Colorectal CancerSpain, Italy, Singapore, Canada, Israel, Korea, Republic of, Netherlands, Australia
-
National University Hospital, SingaporePrince of Wales Hospital, Shatin, Hong Kong; Apollo Gleneagles Hospitals, KolkataUnknownGastric Cancer | Colon CancerSingapore, India, China
-
SanofiRegeneron PharmaceuticalsCompletedColorectal Cancer MetastaticTaiwan, China, Hong Kong, Japan, Singapore
-
Array BioPharmaCompletedMetastatic Colorectal CancerUnited States, Australia, Belgium, Canada, France, Israel, Italy, Netherlands, Singapore, Spain
-
Novartis PharmaceuticalsActive, not recruitingBRAF V600 Colorectal CancerBelgium, Germany, Netherlands, Spain, Singapore, Australia, United Kingdom, Israel, Canada, United States
-
Novartis PharmaceuticalsRecruitingCarcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Colorectal Cancer | Non-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Carcinoma, Non-Small Cell Lung | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, Colorectal | Non-Small Cell Lung Carcinoma | KRAS G12C Mutant Solid TumorsKorea, Republic of, Spain, Belgium, United States, France, Germany, Italy, Singapore
-
Novartis PharmaceuticalsRecruitingMSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal CancersJapan, Spain, Singapore, Belgium, Germany, Korea, Republic of, Taiwan, France, Israel, Norway, United States
-
Sichuan Huiyang Life Science and Technology CorporationCompletedMelanoma | Carcinoma, Renal Cell | Carcinoma, Non-Small-Cell Lung | Carcinoma, Hepatocellular | Colon CancerSingapore
-
Novartis PharmaceuticalsCompletedColorectal Cancer, Triple Negative Breast Cancer, NSCLC - AdenocarcinomaUnited States, France, Taiwan, Canada, Italy, Singapore, Belgium, Spain, Israel
-
Novartis PharmaceuticalsActive, not recruitingMetastatic Colorectal CancerCanada, Taiwan, Belgium, Germany, Spain, Italy, Czechia, Switzerland, Australia, United States, Japan, Singapore, United Kingdom, France, Israel, Hong Kong, Korea, Republic of
-
National Cancer Institute (NCI)CompletedAdenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage IV Pancreatic CancerUnited States, Singapore, Australia
-
NantCell, Inc.CompletedMetastatic Colorectal CancerUnited States, Italy, France, Russian Federation, Spain, Hungary, Poland, Singapore, Hong Kong, India
-
Mirati Therapeutics Inc.Active, not recruitingMetastatic Colorectal Cancer | Advanced Colorectal CancerUnited States, Denmark, Finland, Italy, Spain, Belgium, Romania, Taiwan, Thailand, France, Germany, Korea, Republic of, China, Malaysia, Hong Kong, Australia, Austria, Puerto Rico, Singapore, Canada, Portugal, Poland, Greece, United Kingdom and more
-
Boston Scientific CorporationBiocompatibles UK LtdCompletedColorectal Cancer MetastaticKorea, Republic of, Canada, United States, Belgium, Spain, United Kingdom, France, Germany, Austria, Singapore, China, Italy, Poland
-
PfizerCompletedMetastatic Colorectal CancerBelgium, Bulgaria, Hungary, Spain, Ukraine, Germany, Ireland, Korea, Republic of, Poland, Portugal, Russian Federation, Slovakia, Sweden, Mexico, Serbia, Singapore, Taiwan, Thailand, United Kingdom, Cyprus, Czech Republic, India, Ar... and more
-
Sirtex MedicalCompletedColorectal Cancer MetastaticUnited States, France, Korea, Republic of, Australia, Israel, Singapore, Belgium, Taiwan, Spain, New Zealand, Portugal, Germany, Italy
-
AmgenCompletedMetastatic Colorectal CancerSweden, Belgium, Czechia, Italy, Poland, United States, France, Korea, Republic of, Peru, Philippines, Russian Federation, United Kingdom, China, Canada, Israel, Lithuania, Australia, South Africa, Bulgaria, Romania, Taiwan, Latvia, Serbi... and more
-
Merck KGaA, Darmstadt, GermanyCompletedEpidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal CancerSweden, Australia, Brazil, Bulgaria, France, Italy, Korea, Republic of, Russian Federation, South Africa, Spain, Turkey, United Kingdom, Germany, Hungary, Poland, Romania, Austria, Belgium, Finland, Netherlands, Slovakia, Greece, Ta... and more
-
National Cancer Centre, SingaporeUniversity of Sydney; Australasian Gastro-Intestinal Trials Group; INDOX Cancer...Active, not recruitingColorectal CancerAustralia, Saudi Arabia, India, China, Malaysia, Korea, Republic of, Singapore, Indonesia, New Zealand, Sri Lanka